Nov 2023: Hukumar Abinci da Magunguna ta amince da HEPZATO KIT (melphalan don Injection/Hepatic Delivery System, Delcath Systems, Inc.) a matsayin jiyya ta hanta ga manya marasa lafiya tare da uveal melanoma waɗanda ke da h..
SHANGHAI, CHINA, Fabrairu 28, 2023 - JW Therapeutics (HKEX: 2126), wani kamfani mai zaman kansa kuma mai haɓaka fasahar kere kere wanda ke mai da hankali kan haɓakawa, masana'antu da kasuwancin samfuran rigakafin ƙwayoyin cuta, ya sanar da init.
Nuwamba 2022: Hukumar Abinci da Magunguna ta amince da tremelimumab (Imjudo, AstraZeneca Pharmaceuticals) a haɗe tare da durvalumab ga manya marasa lafiya waɗanda ke da ciwon hanta da ba a iya gano su ba (uHCC). An kimanta inganci..
Dec 2021: An amince da waɗannan magunguna masu zuwa zuwa kwanan wata don maganin ciwon hanta:. Da fatan za a bincika bayanan rubutawa kafin shan magani. Atezolizumab Avastin (Bevacizumab) Bevacizumab Cabometyx (Cabozantinib-SM..
July 14, 2021: Check out interview of Dr. Selvakumar Naganathan - Clinical Lead - Liver transplantation and HPB surgery, Apollo Hospitals, Chennai. Check out the video and also excerpts of the interview. https://www.youtube.com..
Yuli 13th 2021: Wani sabon magani na mutanen da suke da wani irin ciwon hanta wanda ake kira carcinoma hepatocellular yana samuwa wanda ya nuna yafi kyau fiye da daidaitaccen magani (HCC). Hukumar Abinci da Magunguna (FDA) ta amince da atezoliz ..
A ranar 14 ga Janairu, 2019, Cabozantinib (CABOMETYX, Exelixis, Inc.) ya amince da Hukumar Abinci da Magunguna don marasa lafiya da ciwon hanta (HCC) waɗanda a baya aka yi musu magani tare da sorafenib. A appr..
Nauyin ciwon kansar hanta Ciwon hanta cuta ce ta kowa da kowa wanda ke lissafin fiye da rabin cutar kansar hanta a duniya. Farkon ciwon hanta (HCC) yana ɓoye, kuma alamun farko ba a bayyane suke ba. Yawancin mutane..
Ciwon daji na hanta a halin yanzu cutar kansar hanta ita ce ta biyar mafi yawan mace-mace masu alaka da cutar kansa a duniya. Maganin jiyya na tsarin layi na farko na yanzu shine sorafenib, amma yawanci yana tsawaita rayuwar gaba ɗaya na watanni 3.
Laifukan NK cell immunotherapy don ciwon hanta mai ci gaba mai shekaru 92 mai fama da ciwon daji ya sami cikakkiyar gafara Shekaru bakwai da suka wuce, Ms. M, wanda ke cikin 80s, an gano shi da ciwon daji na hepatocellular (wanda ya haifar da ciwon daji a cikin p ..